Valve-in-valve transcatheter aortic valve replacement to treat multijet paravalvular regurgitation: A case series and review.

Clinical Cardiology
Morgan H RandallThomas M Beaver

Abstract

Treatment advances for severe symptomatic aortic stenosis including transcatheter and open surgical valve replacement have improved patient survival, length of stay, and speed to recovery. However, paravalvular regurgitation (PVR) is occasionally seen and when moderate or greater in severity is associated with an at least 2-fold increase in 1 year mortality. While several treatment approaches focused on single-jet PVR have been described in the literature, few reports describe multijet PVR. Multijet PVR can successfully be treated with a variety of catheter-based options including valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR). We present two patients with at least moderate PVR following aortic valve replacement who were successfully treated with ViV TAVR along with a review of literature highlighting our rationale for utilizing each management approach. Multijet PVR can be treated successfully with ViV TAVR, but additional options such as self-expanding occluder devices and bioprosthetic valve fracture have a role as adjunctive treatments to achieve optimal results. The etiology of multijet PVR can differ between patients, this heterogeneity underscores the paucity of data to guide treatment strategies. The...Continue Reading

References

Oct 22, 2010·The New England Journal of Medicine·Martin B LeonUNKNOWN PARTNER Trial Investigators
Feb 5, 2015·The Journal of Thoracic and Cardiovascular Surgery·Maurizio TaramassoOttavio Alfieri
Apr 5, 2016·The New England Journal of Medicine·Martin B LeonUNKNOWN PARTNER 2 Investigators
May 25, 2016·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Abhijeet DhobleRaj Makkar
Jul 12, 2016·International Journal of Cardiology·Hisato TakagiUNKNOWN ALICE (All-Literature Investigation of Cardiovascular Evidence) Group
Mar 11, 2017·JACC. Cardiovascular Interventions·John A WellsVasilis Babaliaros
Aug 3, 2017·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Thomas M WaterburyMackram F Eleid
Sep 25, 2017·The Annals of Thoracic Surgery·Pranav LoyalkaKeshava Rajagopal
Mar 8, 2018·Current Cardiology Reports·Kashish Goel, Mackram F Eleid
Apr 27, 2018·Heart·Mackram Eleid
Jun 28, 2018·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Nicolas WernerRalf Zahn
Aug 17, 2018·The Thoracic and Cardiovascular Surgeon·Hisato TakagiTomo Ando
Sep 14, 2018·Irish Journal of Medical Science·Richard TannerIvan P Casserly
Jan 20, 2019·Nature Reviews. Cardiology·Joel P GiblettPatrick A Calvert
Mar 13, 2019·The Journal of Thoracic and Cardiovascular Surgery·Keith B AllenUNKNOWN Bioprosthetic Valve Fracture Investigators
Mar 19, 2019·The New England Journal of Medicine·Michael J MackUNKNOWN PARTNER 3 Investigators
Jul 4, 2019·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Hector A Alvarez-CovarrubiasA Markus Kasel
Aug 1, 2019·Journal of Cardiovascular Translational Research·Paolo PeruzzoAndrea Colli
Sep 4, 2019·Journal of Cardiac Surgery·Dinu V BalanescuSerban M Balanescu
Nov 16, 2019·Current Treatment Options in Cardiovascular Medicine·Samuel Bernard, Evin Yucel
Jan 25, 2020·JACC. Cardiovascular Interventions·John K ForrestMichael J Reardon
Mar 1, 2020·Cardiology and Therapy·Morgan H Randall, Anthony A Bavry

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
coronary artery bypass

Software Mentioned

Evolut
ViV

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.